Singapore-primarily based wellness tech startup Neurowyzr has effectively elevated an additional $2.1 million in an oversubscribed seed funding round. The company is building state-of-the-art options for early brain drop, leveraging the most up-to-date breakthroughs in neuroscience to enhance mind health and fitness and general performance.
The new funding spherical, which delivers the complete raised by the enterprise to $3.3 million, was jointly led by Jungle Ventures and Peak XV’s Surge. The funds will be channeled toward accelerating item progress and initiating the up coming stage of the company’s expansion in Southeast Asia and India.
In line with the Environment Wellness Organisation’s connect with for improved exploration into scientific applications for measuring mind health, Neurowyzr is targeted on addressing early brain decline, a phase the place timely detection and intervention can substantially influence protecting against further more deterioration.
“Brain drop is a probably debilitating situation that strikes fear in quite a few people today, and brings huge cost on families and societies,” stated Pang Sze Yunn, CEO of Neurowyzr. “Neurowyzr aims to address the unmet requires of individuals to shield their mind well being. We are grateful for the rely on that our traders have demonstrated in us, and are energized that the partnership will enable us to make mind health accessible and economical.”
The company’s guide item is a digital neuroscience assessment created to considerably lower the time and fiscal burden involved with regular cognitive tests. In Singapore, the solution is currently readily available at quite a few health screening facilities, basic practitioner clinics, local community care services, and specialist facilities.
“Projected quantities tell a stark story for Asia: over the upcoming two many years, extra than 66 million people could confront dementia, when Delicate Cognitive Impairment could have an effect on more than 400 million,” mentioned Seemant Jauhari, partner at Jungle Ventures. “Neurowyzr is a immediate reaction to this obstacle. By evaluating brain and mental wellbeing instantly, we’re making a proactive defence against a opportunity epidemic. This Singapore-born solution carries a global impact.”
Recognized in 2019 by Nav Vij and Pang Sze Yunn, Neurowyzr offers a scientific advisory staff comprising Dr Prem Pillay, Director of the Singapore Mind Nerve Backbone Centre, and Professor N Kandiah, Director of the Dementia Investigate Centre at Nanyang Technological College (NTU).